EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of lncRNA PCAT19 promotes breast cancer proliferation

Jianyuan Feng, Jiarui Zhang, Yanling Li, Weilun Cheng, Yansong Liu, Ziang Chen, Yunqiang Duan, Tianshui Yu, Anbang Hu, Ting Wang, Hanyu Zhang, Mingcui Li und 3 weitere

Cancer Medicine · 2023

DOI: 10.1002/cam4.5872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jianyuan Feng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, China. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer (BC) is the most common malignancy affecting women. It is vital to explore sensitive biological markers to diagnose and treat BC patients. Recent studies have proved that long noncoding RNAs (lncRNAs) were involved in breast tumor progression. Nonetheless, whether lncRNA prostate cancer‐associated transcript 19 (PCAT19) impacts BC development remains unknown.

Methods

We performed various bioinformatic analyses, including machine learning models to identify critical regulatory lncRNAs affecting prognosis in BC. The in situ hybridization (ISH) assay was carried out to confirm the expression levels of lncRNA PCAT19 in tissue specimens. MTT assay, wound healing assay, and transwell assay were performed to investigate PCAT19's impact on proliferation, migration, and invasion of BC cells. Mouse xenografts were used to examine the proliferation‐inhibiting function of PCAT19 in vivo.

Results

Among the prognosis‐associated lncRNAs, PCAT19 predicted a favorable prognosis in BC. Patients with high expression levels of PCAT19 had a lower clinical stage and less lymph node metastasis. The PCAT19‐related genes were enriched in signaling pathways involved in tumor development, indicating PCAT19 was an essential regulator of BC. Using the ISH assay, we confirmed the expression level of lncRNA PCAT19 in human BC tissues was lower than normal breast tissues. Moreover, the knockdown of PCAT19 further confirmed its inhibiting ability in BC cell proliferation. Correspondingly, overexpressing PCAT19 reduced tumor size in mouse xenografts.

Conclusions

Our study demonstrated that lncRNA PCAT19 suppressed the development of BC. PCAT19 might be a promising prognostic biomarker, which provides new insights into risk stratification for BC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRNA, Long NoncodingMicroRNAsMaleHumansFemaleAnimalsMiceCell Line, TumorPrognosisCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

bioinformaticsbreast cancerlong noncoding RNAtumor biology

Substanzen

RNA, Long NoncodingMicroRNAs

Autor:innen und Institutionen

  • Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, China.

ORCID-Profile: Baoliang Guo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, J., Zhang, J., Li, Y., Cheng, W., Liu, Y., Chen, Z., Duan, Y., Yu, T., Hu, A., Wang, T., Zhang, H., Li, M., Rong, Z., Ma, F., & Guo, B. (2023). Inhibition of lncRNA PCAT19 promotes breast cancer proliferation. Cancer Medicine. https://doi.org/10.1002/cam4.5872

Vancouver

Feng J, Zhang J, Li Y, Cheng W, Liu Y, Chen Z, et al. Inhibition of lncRNA PCAT19 promotes breast cancer proliferation. Cancer Medicine. 2023. doi:10.1002/cam4.5872

BibTeX
@article{Feng2023,
  author = {Feng, Jianyuan and Zhang, Jiarui and Li, Yanling and Cheng, Weilun and Liu, Yansong and Chen, Ziang and Duan, Yunqiang and Yu, Tianshui and Hu, Anbang and Wang, Ting and Zhang, Hanyu and Li, Mingcui and Rong, Zhiyuan and Ma, Fei and Guo, Baoliang},
  title = {Inhibition of lncRNA PCAT19 promotes breast cancer proliferation},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5872}
}
Kostenlos starten →